What the NDAA Means for the Future of Biotech
This episode breaks down how Congress is turning biotechnology into a core national security priority. John Stanford explains the biggest shifts in the 2025 defense bill, why China-focused guardrails are expanding, and how new investment rules could reshape biotech funding. We also cover a new bipartisan proposal to create a government-backed investment fund, and a high-stakes battle over ACA subsidies.
What NDAA change do you think will impact biotech most?
Should the U.S. invest directly in emerging biotechnologies?
How should policymakers balance security with scientific innovation?
If…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.